1. Home
  2. DSM vs CGC Comparison

DSM vs CGC Comparison

Compare DSM & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BNY Mellon Strategic Municipal Bond Fund Inc.

DSM

BNY Mellon Strategic Municipal Bond Fund Inc.

N/A

Current Price

$5.66

Market Cap

256.5M

Sector

Finance

ML Signal

N/A

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

N/A

Current Price

$0.65

Market Cap

299.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSM
CGC
Founded
1989
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.5M
299.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
DSM
CGC
Price
$5.66
$0.65
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $1.98
AVG Volume (30 Days)
196.4K
★ 2.4M
Earning Date
01-01-0001
11-06-2026
Dividend Yield
★ 3.97%
N/A
EPS Growth
N/A
★ 84.17
EPS
★ N/A
N/A
Revenue
N/A
★ $12,759,000.00
Revenue This Year
N/A
$18.83
Revenue Next Year
N/A
$7.72
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.07
$0.64
52 Week High
$6.30
$2.38

Technical Indicators

Market Signals
Indicator
DSM
CGC
Relative Strength Index (RSI) 67.95 32.43
Support Level N/A N/A
Resistance Level $6.21 $1.08
Average True Range (ATR) 0.08 0.04
MACD 0.04 0.01
Stochastic Oscillator 97.52 20.47

Price Performance

Historical Comparison
DSM
CGC

About DSM BNY Mellon Strategic Municipal Bond Fund Inc.

BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: